Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives

Molecular Pharmaceutics

Volumn 13, Issue 3, 2016, Pages 873-884

  Xie, Tian ^a   Taylor, Lynne S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

amorphous solid dispersions; crystallization; drug release; miscibility; supersaturation

Indexed keywords

CELECOXIB; CELLULOSE DERIVATIVE; HYDROXYPROPYLMETHYLCELLULOSE; POLYACRYLIC ACID; SUCCINIC ACID; ACRYLIC ACID RESIN; CARBOPOL 940; DRUG CARRIER; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; METHYLCELLULOSE; POLYMER;

ARTICLE; CRYSTAL; CRYSTALLIZATION; DISPERSION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; GROWTH RATE; HYDRATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG STABILITY; MEDICINAL CHEMISTRY; METABOLISM; SOLUBILITY;

ACRYLIC RESINS; CELECOXIB; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; HYPROMELLOSE DERIVATIVES; METHYLCELLULOSE; POLYMERS; SOLUBILITY;

EID: 84960099183     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.5b00798     Document Type: Article

References (49)

1. Babu, N. J.; Nangia, A. Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals Cryst. Growth Des. 2011, 11 (7) 2662-2679 10.1021/cg200492w
2. Williams, H. D.; Trevaskis, N. L.; Charman, S. A.; Shanker, R. M.; Charman, W. N.; Pouton, C. W.; Porter, C. J. H. Strategies to Address Low Drug Solubility in Discovery and Development Pharmacol. Rev. 2013, 65 (1) 315-499 10.1124/pr.112.005660
3. Brouwers, J.; Brewster, M. E.; Augustijns, P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J. Pharm. Sci. 2009, 98 (8) 2549-72 10.1002/jps.21650
4. Raina, S. A.; Zhang, G. G. Z.; Alonzo, D. E.; Wu, J.; Zhu, D.; Catron, N. D.; Gao, Y.; Taylor, L. S. Enhancements and Limits in Drug Membrane Transport Using Supersaturated Solutions of Poorly Water Soluble Drugs J. Pharm. Sci. 2014, 103 (9) 2736-2748 10.1002/jps.23826
5. Dahan, A.; Miller, J. M. The Solubility-Permeability Interplay and Its Implications in Formulation Design and Development for Poorly Soluble Drugs AAPS J. 2012, 14 (2) 244-251 10.1208/s12248-012-9337-6
6. Morgen, M.; Bloom, C.; Beyerinck, R.; Bello, A.; Song, W.; Wilkinson, K.; Steenwyk, R.; Shamblin, S. Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability Drug Pharm. Res. 2012, 29 (2) 427-440 10.1007/s11095-011-0558-7
7. Vasconcelos, T.; Sarmento, B.; Costa, P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discovery Today 2007, 12 (23-24) 1068-1075 10.1016/j.drudis.2007.09.005
8. Corrigan, O. I. Mechanisms of Dissolution of Fast Release Solid Dispersions Drug Dev. Ind. Pharm. 1985, 11 (2-3) 697-724 10.3109/03639048509056896
9. Chiou, W. L.; Riegelman, S. Pharmaceutical applications of solid dispersion systems J. Pharm. Sci. 1971, 60 (9) 1281-1302 10.1002/jps.2600600902
10. Paudel, A.; Worku, Z. A.; Meeus, J.; Guns, S.; Van den Mooter, G. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: Formulation and process considerations Int. J. Pharm. 2013, 453 (1) 253-284 10.1016/j.ijpharm.2012.07.015
11. Alonzo, D. E.; Zhang, G. G. Z.; Zhou, D. L.; Gao, Y.; Taylor, L. S. Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution Pharm. Res. 2010, 27 (4) 608-618 10.1007/s11095-009-0021-1
12. Ewing, A. V.; Clarke, G. S.; Kazarian, S. G. Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging Eur. J. Pharm. Sci. 2014, 60, 64-71 10.1016/j.ejps.2014.05.001
13. Raghavan, S. L.; Trividic, A.; Davis, A. F.; Hadgraft, J. Crystallization of hydrocortisone acetate: influence of polymers Int. J. Pharm. 2001, 212 (2) 213-221 10.1016/S0378-5173(00)00610-4
14. Suzuki, H.; Sunada, H. Influence of Water-Soluble Polymers on the Dissolution of Nifedipine Solid Dispersions with Combined Carriers Chem. Pharm. Bull. 1998, 46 (3) 482-487 10.1248/cpb.46.482
15. Alonzo, D. E.; Gao, Y.; Zhou, D.; Mo, H.; Zhang, G. G. Z.; Taylor, L. S. Dissolution and precipitation behavior of amorphous solid dispersions J. Pharm. Sci. 2011, 100 (8) 3316-3331 10.1002/jps.22579
16. Simonelli, A. P.; Mehta, S. C.; Higuchi, W. I. Dissolution Rates of High Energy Polyvinylpyrrolidone (pvp)-sulfathiazole Coprecipitates J. Pharm. Sci. 1969, 58 (5) 538-549 10.1002/jps.2600580503
17. Simonelli, A. P.; Mehta, S. C.; Higuchi, W. I. Dissolution Rates of High Energy Polyvinylpyrrolidone (PVP)-Sulfathiazole Coprecipitates J. Pharm. Sci. 1969, 58 (5) 538-549 10.1002/jps.2600580503
18. Paulson, S. K.; Vaughn, M. B.; Jessen, S. M.; Lawal, Y.; Gresk, C. J.; Yan, B.; Maziasz, T. J.; Cook, C. S.; Karim, A. Pharmacokinetics of Celecoxib after Oral Administration in Dogs and Humans: Effect of Food and Site of Absorption J. Pharmacol. Exp. Ther. 2001, 297 (2) 638-645
19. Gupta, P.; Kakumanu, V. K.; Bansal, A. K. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective Pharm. Res. 2004, 21 (10) 1762-9 10.1023/B:PHAM.0000045226.42859.b8
20. Abu-Diak, O. A.; Jones, D. S.; Andrews, G. P. An Investigation into the Dissolution Properties of Celecoxib Melt Extrudates: Understanding the Role of Polymer Type and Concentration in Stabilizing Supersaturated Drug Concentrations Mol. Pharmaceutics 2011, 8 (4) 1362-1371 10.1021/mp200157b
21. Albers, J.; Alles, R.; Matthée, K.; Knop, K.; Nahrup, J. S.; Kleinebudde, P. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion Eur. J. Pharm. Biopharm. 2009, 71 (2) 387-394 10.1016/j.ejpb.2008.10.002
22. Dong, J.; Ozaki, Y.; Nakashima, K. Infrared, Raman, and Near-Infrared Spectroscopic Evidence for the Coexistence of Various Hydrogen-Bond Forms in Poly(acrylic acid) Macromolecules 1997, 30 (4) 1111-1117 10.1021/ma960693x
23. Ilevbare, G. A.; Liu, H.; Edgar, K. J.; Taylor, L. S. Maintaining Supersaturation in Aqueous Drug Solutions: Impact of Different Polymers on Induction Times Cryst. Growth Des. 2012, 13 (2) 740-751 10.1021/cg301447d
24. Trasi, N. S.; Oucherif, K. A.; Litster, J. D.; Taylor, L. S. Evaluating the influence of polymers on nucleation and growth in supersaturated solutions of acetaminophen CrystEngComm 2015, 17 (6) 1242-1248 10.1039/C4CE02179G
25. Janssens, S.; Van den Mooter, G. Review: physical chemistry of solid dispersions J. Pharm. Pharmacol. 2009, 61 (12) 1571-1586 10.1211/jpp.61.12.0001
26. Curatolo, W.; Nightingale, J.; Herbig, S. Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu Pharm. Res. 2009, 26 (6) 1419-1431 10.1007/s11095-009-9852-z
27. Warren, D. B.; Benameur, H.; Porter, C. J.; Pouton, C. W. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility J. Drug Target 2010, 18 (10) 704-731 10.3109/1061186X.2010.525652
28. Curatolo, W.; Nightingale, J. A.; Herbig, S. M. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu Pharm. Res. 2009, 26 (6) 1419-1431 10.1007/s11095-009-9852-z
29. Ilevbare, G. A.; Liu, H. Y.; Edgar, K. J.; Taylor, L. S. Maintaining Supersaturation in Aqueous Drug Solutions: Impact of Different Polymers on Induction Times Cryst. Growth Des. 2013, 13 (2) 740-751 10.1021/cg301447d
30. Mullin, J. W. Crystallization; Butterworth-Heinemann, 2001.
31. Murdande, S. B.; Pikal, M. J.; Shanker, R. M.; Bogner, R. H. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis J. Pharm. Sci. 2010, 99 (3) 1254-1264 10.1002/jps.21903
32. Almeida e Sousa, L.; Reutzel-Edens, S. M.; Stephenson, G. A.; Taylor, L. S. Assessment of the Amorphous "Solubility" of a Group of Diverse Drugs Using New Experimental and Theoretical Approaches Mol. Pharmaceutics 2015, 12 (2) 484-495 10.1021/mp500571m
33. Chen, J.; Ormes, J. D.; Higgins, J. D.; Taylor, L. S. Impact of Surfactants on the Crystallization of Aqueous Suspensions of Celecoxib Amorphous Solid Dispersion Spray Dried Particles Mol. Pharmaceutics 2015, 12 (2) 533-541 10.1021/mp5006245
34. Van Eerdenbrugh, B.; Raina, S.; Hsieh, Y.-L.; Augustijns, P.; Taylor, L. Classification of the Crystallization Behavior of Amorphous Active Pharmaceutical Ingredients in Aqueous Environments Pharm. Res. 2014, 31 (4) 969-982 10.1007/s11095-013-1216-z
35. Sohnel, O.; Mullin, J. W. Interpretation of Crystallization Induction Periods J. Colloid Interface Sci. 1988, 123 (1) 43-50 10.1016/0021-9797(88)90219-6
36. Schram, C. J.; Taylor, L. S.; Beaudoin, S. P. Influence of Polymers on the Crystal Growth Rate of Felodipine: Correlating Adsorbed Polymer Surface Coverage to Solution Crystal Growth Inhibition Langmuir 2015, 31, 11279 10.1021/acs.langmuir.5b02486
37. Kurkuri, M. D.; Aminabhavi, T. M. Poly(vinyl alcohol) and poly(acrylic acid) sequential interpenetrating network pH-sensitive microspheres for the delivery of diclofenac sodium to the intestine J. Controlled Release 2004, 96 (1) 9-20 10.1016/j.jconrel.2003.12.025
38. Chawla, G.; Gupta, P.; Thilagavathi, R.; Chakraborti, A. K.; Bansal, A. K. Characterization of solid-state forms of celecoxib Eur. J. Pharm. Sci. 2003, 20 (3) 305-317 10.1016/S0928-0987(03)00201-X
39. Alonzo, D. E.; Raina, S.; Zhou, D.; Gao, Y.; Zhang, G. G. Z.; Taylor, L. S. Characterizing the Impact of Hydroxypropylmethyl Cellulose on the Growth and Nucleation Kinetics of Felodipine from Supersaturated Solutions Cryst. Growth Des. 2012, 12 (3) 1538-1547 10.1021/cg201590j
40. Ilevbare, G. A.; Liu, H.; Edgar, K. J.; Taylor, L. S. Inhibition of solution crystal growth of ritonavir by cellulose polymers-factors influencing polymer effectiveness CrystEngComm 2012, 14 (20) 6503-6514 10.1039/c2ce25515d
41. Kubota, N.; Mullin, J. W. A kinetic model for crystal growth from aqueous solution in the presence of impurity J. Cryst. Growth 1995, 152 (3) 203-208 10.1016/0022-0248(95)00128-X
42. Verdoes, D.; Kashchiev, D.; van Rosmalen, G. M. Determination of nucleation and growth rates from induction times in seeded and unseeded precipitation of calcium carbonate J. Cryst. Growth 1992, 118 (3-4) 401-413 10.1016/0022-0248(92)90089-2
43. Qian, F.; Huang, J.; Hussain, M. A. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development J. Pharm. Sci. 2010, 99 (7) 2941-2947 10.1002/jps.22074
44. Kuo, S.-W.; Shih, C.-C.; Shieh, J.-S.; Chang, F.-C. Specific interactions in miscible polymer blends of poly(2-hydroxypropyl methacrylate) with polyvinylpyrrolidone Polym. Int. 2004, 53 (2) 218-224 10.1002/pi.1271
45. Silverstein, R. M.; Webster, F. X.; Kiemle, D.; Bryce, D. L. Spectrometric Identification of Organic Compounds; John Wiley & Sons, 2014.
46. Coleman, M. M.; Painter, P. C.; Graf, J. F. Specific Interactions and the Miscibility of Polymer Blends; CRC Press, 1995.
47. Marsac, P.; Shamblin, S.; Taylor, L. S. Theoretical and Practical Approaches for Prediction of Drug-Polymer Miscibility and Solubility Pharm. Res. 2006, 23 (10) 2417-2426 10.1007/s11095-006-9063-9
48. Rumondor, A. F.; Ivanisevic, I.; Bates, S.; Alonzo, D.; Taylor, L. S. Evaluation of Drug-Polymer Miscibility in Amorphous Solid Dispersion Systems Pharm. Res. 2009, 26 (11) 2523-2534 10.1007/s11095-009-9970-7
49. Marks, J. A.; Wegiel, L. A.; Taylor, L. S.; Edgar, K. J. Pairwise Polymer Blends for Oral Drug Delivery J. Pharm. Sci. 2014, 103 (9) 2871-2883 10.1002/jps.23991